| Financial Year |
March 31 2023 |
| Monetary Funds |
805,811,705.29 |
| Held-for-trading Financial Assets |
543,052,282.25 |
| Notes Receivable |
17,937,900.02 |
| Accounts Receivable |
1,954,353,687.80 |
| Advances to Suppliers |
163,844,119.12 |
| Other Receivables |
19,125,912.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,125,736,819.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
120,118,362.75 |
| Total Current Assets |
4,768,052,825.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,136,703.53 |
| Investment Properties |
67,912,614.55 |
| Fixed Assetes |
1,969,444,188.36 |
| Under-construction Projects |
545,780,759.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
261,801,932.61 |
| R&D expenses |
120,202,091.97 |
| Goodwill |
145,145,637.79 |
| Long-Term Deferred and Prepaid Expenses |
9,905,084.34 |
| Deferred Income Tax Assets |
167,902,329.48 |
| Other Non-Current Assets |
5,748,407.43 |
| Sub-Total of Non-Current Assets |
3,502,603,372.83 |
| Total Assets |
8,270,656,198.29 |
| Short-Term Loans |
233,822,506.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,233,004.45 |
| Accounts Payable |
380,012,213.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,408,655.38 |
| Taxes Payable |
74,819,416.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,713,101.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
152,374,655.25 |
| Other Current Liabilities |
10,359,373.13 |
| Sub-Total of Current Liabilities |
1,024,382,408.50 |
| Long-term Loans |
332,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
226,550,066.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
607,528,782.61 |
| Total Liabilities |
1,631,911,191.11 |
| Paid-In Capital(Or Share Stock) |
612,469,590.00 |
| Capital Surplus |
1,780,970,540.04 |
| Surplus Reserve |
306,234,795.00 |
| LESS:Treasury Stock |
170,181,677.97 |
| Undistributed Profits |
3,857,118,451.27 |
| Minority Stockholder's Interest |
237,172,319.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,401,572,687.34 |
| Owner's Equity（Stockholder's Equity） |
6,638,745,007.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,270,656,198.29 |
